Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin (2009)
Fonte: Clinica Lipidology. Unidade: FCF
Assuntos: DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, GENOMAS
ABNT
HIRATA, Rosario Dominguez Crespo e HIRATA, Mario Hiroyuki. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, v. 4, n. 4, p. 419-423, 2009Tradução . . Disponível em: https://doi.org/10.2217/clp.09.32. Acesso em: 16 ago. 2024.APA
Hirata, R. D. C., & Hirata, M. H. (2009). Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, 4( 4), 419-423. doi:10.2217/clp.09.32NLM
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 ago. 16 ] Available from: https://doi.org/10.2217/clp.09.32Vancouver
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 ago. 16 ] Available from: https://doi.org/10.2217/clp.09.32